ArticleJournal of neurology2022

Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience.

Claudia Altamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.